News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
289–324
Matches
895
Sources here
21
Companies here
18
Search results Stored financial headlines

Active search

895 matching headlines

Ticker or company: NECMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Fennec sets Aug. 11 call to discuss second-quarter results

Fennec Pharmaceuticals (NASDAQ: FENC; TSX: FRX) announced it will release its second-quarter 2026 financial results before the U.S. market opens on Tuesday, August 11, 2026. A conference call and webcast will follow at 8:30 a.m. Eastern Time to discuss the financial and business results. …

FRX main company FENC main company
Sharemaestro market context Trend signal active 52 weeks +42.5% FRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

RESEARCH TRIANGLE PARK, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its second quarter 2026 financial results before the opening of the U.S. financial markets …

FRX main company
Sharemaestro market context Trend signal active 52 weeks +42.5% FRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Investors May Respond To TE Connectivity (TEL) Earnings Beat And Completion Of Long-Term Buyback

TE Connectivity (TEL) reported higher sales and net income in its past quarter and completed a long-running share repurchase program. This combination of stronger earnings per share and a reduced share count highlights the company's profit growth paired with sustained capital returns. The article …

TEL main company
Sharemaestro market context Price above Trend Line 52 weeks +6.5% TEL stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Unearthing August 2026's Promising Penny Stocks

This article identifies promising penny stocks for August 2026, focusing on companies with potential for growth despite being smaller or newer, while emphasizing the importance of strong balance sheets and solid fundamentals. It highlights three specific companies: Resources Connection (RGP), Tecogen (TGEN), and High …

RGP main company
Sharemaestro market context Trend signal active 52 weeks -9.7% · Next-week setup negative 44.3% RGP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fennec Pharmaceuticals (FENC) Former Director Rosty Raykov Sells 10,000 Shares

Rosty Raykov, a former director of Fennec Pharmaceuticals (FENC), sold 10,000 shares of the company's stock on August 3, 2026, for approximately $95,800. This sale is part of a broader pattern of insider selling, with 18 insider sells and zero buys over the past …

FENC main company
Sharemaestro market context Trend signal active 52 weeks +35.3% FENC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CNOB5000243 Bond Profile — Key Metrics

This article provides a detailed profile of the CNOB5000243 bond issued by ConnectOne Bancorp, Inc. Key metrics such as the coupon rate (9.91%), issue and maturity dates (June 15, 2020, and June 15, 2030, respectively), and face value ($1,000.00) are highlighted. ConnectOne Bancorp, Inc. …

CNOB main company
Sharemaestro market context Trend signal active 52 weeks +32.3% CNOB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Waste Connections (NYSE: WCN) SVP details RSU and share holdings

Waste Connections, Inc. Senior Vice President, Derek M. Dague, has reported his equity awards and common share holdings. These holdings include both time-based and performance-based Restricted Share Units (RSUs) that vest over several years, along with 1,773 directly held common shares. The performance-based RSUs …

WCN main company
Sharemaestro market context Price above Trend Line 52 weeks -9.4% · Next-week setup positive 56.0% WCN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ConnectOne Bancorp, Inc. Q2 2026: Revenue $200.8M, EPS $0.8— 10-Q Summary

ConnectOne Bancorp, Inc. (CNOB) reported strong second-quarter 2026 results, with revenue reaching $200.8 million and diluted EPS at $0.80. The company returned to profitability, driven by increased net interest income, expanded margins, and the full inclusion of recently acquired operations. Key highlights include significant …

CNOB main company
Sharemaestro market context Trend signal active 52 weeks +32.3% CNOB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trash to be picked up one day a week in Union

The city of Union will consolidate trash pickup to one day per week, specifically Mondays, starting in September, with Waste Connections Inc. making the change. City officials expressed concerns about missed pickups and snow days, but Waste Connections assured them of backup trucks. The …

WCN main company
Sharemaestro market context Price above Trend Line 52 weeks -9.4% · Next-week setup positive 56.0% WCN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says

Bristol Myers Squibb's (BMY) reported merger discussions with AstraZeneca (AZN) will unlikely result PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? …

AZN main company AZN1N main company AZN main company A1ZN34 main company AZN main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +14.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intel vs. TSMC: Intel Is Winning an AI Battle Against TSMC That Few Investors Are Watching

Semiconductor by Gorodenkoff via Shutterstock It is not often that TSMC (TSM) takes cues from Intel (INTC), but that is undoubtedly what's happening. According to The Information, the world's largest contract chipmaker is quietly building a new packaging technology modeled on Intel's EMIB. TSMC's …

3189 main company
Sharemaestro market context Trend signal active 52 weeks +746.5% 3189 stored weekly price path from 15 Aug 2025 to 14 Aug 2026

Brokers split on AstraZeneca merger talk as shares recover some ground

Brokers split on AstraZeneca merger talk as shares recover some ground Proactive uses images sourced from Shutterstock Citi has told clients that a large chunk of deal risk is already in AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) share price after Monday's sharp fall, while Deutsche Bank …

AZN main company AZN1N main company AZN main company A1ZN34 main company AZN main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +14.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

UBS Adjusts Price Target on Waste Connections to $176 From $170, Maintains Neutral Rating

UBS has increased its price target for Waste Connections (NYSE: WCN) to $176 from $170, while reiterating a Neutral rating on the stock. This adjustment comes as Waste Connections, an integrated solid waste services company, recently announced the pricing of C$700 million of senior …

WCN main company
Sharemaestro market context Price above Trend Line 52 weeks -9.4% · Next-week setup positive 56.0% WCN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Waste Connections sues LA County for $825M over Chiquita Canyon closure

This story was originally published on Waste Dive. To receive daily news and insights, subscribe to our free daily Waste Dive newsletter. A Waste Connections subsidiary in June sued Los Angeles County authorities over the 2025 closure of the Chiquita Canyon Landfill, which came …

WCN main company WCN main company
Sharemaestro market context Trend signal active 52 weeks -9.1% WCN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AstraZeneca (LSE:AZN) Is In Merger Talks With Bristol Myers For $400 Billion

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. AstraZeneca (LSE:AZN) is reported to be in advanced merger talks with Bristol Myers Squibb. The potential deal could create a combined pharmaceutical company valued at about US$400b. …

AZN main company AZN1N main company AZN main company A1ZN34 main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +14.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector. Continue Reading

AZN main company AZN1N main company AZN main company A1ZN34 main company AZN main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +14.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CNXN Q2 Deep Dive: AI Adoption and Modernization Drive Broad-Based Growth

CNXN Q2 Deep Dive: AI Adoption and Modernization Drive Broad-Based Growth IT solutions provider Connection (NASDAQ:CNXN) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 12.4% year on year to $854 million. Its non-GAAP profit of $1.31 per share was 26% above …

CNXN main company
Sharemaestro market context Trend signal active 52 weeks +26.4% CNXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

BOSTON and ROLLE, Switzerland, Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN).SOPHiA GENETICS Logo This multi-year collaboration agreement will advance …

AZN1N main company AZN main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks -10.0% · Next-week setup negative 16.9% AZN1N stored weekly price path from 22 Aug 2025 to 14 Aug 2026

My AstraZeneca shares just crashed 9.7%! Here’s why I’m NOT selling

AstraZeneca shares dropped significantly due to rumors of a potential mega-merger with Bristol Myers Squibb and a failed late-stage trial for its heart disease program, Wainua. Despite these setbacks, an investor is not selling, viewing the decline as a market overreaction rather than a …

AZN main company ASTRAZEN main company
Sharemaestro market context Price below Trend Line 52 weeks -1.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

More Biotech M&A Is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not

Even if a megamerger fails to materialize, investors stand to benefit from a wave of M&A activity in the biopharma sector. Continue Reading

AZN main company AZN1N main company AZN main company A1ZN34 main company AZN main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +14.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CNOB5000243 Bond Redemption Profile

This page provides a redemption profile for the CNOB5000243 bond issued by ConnectOne Bancorp, Inc., detailing its overview, coupon rate (9.91498%), and maturity date (June 15, 2030). It explains bond redemption as the full repayment of principal and accrued interest, highlighting the importance of …

CNOB main company
Sharemaestro market context Trend signal active 52 weeks +32.3% CNOB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bristol-Myers Squibb, AstraZeneca deal talks remain active - report

A recent report indicates that deal talks between AstraZeneca and Bristol-Myers Squibb are still ongoing. Following this news, Bristol-Myers Squibb's shares saw a slight increase, while AstraZeneca's shares experienced a minor decline. This update follows an earlier Financial Times report about potential acquisition discussions.

AZN main company
Sharemaestro market context Price below Trend Line 52 weeks -1.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AstraZeneca and Bristol-Myers Squibb: Megamerger Reports Leave Us Scratching Our Heads

Morningstar reports on the potential megamerger between Bristol-Myers Squibb and AstraZeneca, noting that such large acquisitions are rare in biopharma. While the deal could combine complementary patent portfolios and pipeline assets, concerns exist regarding integration challenges and regulatory hurdles due to overlapping oncology focuses. …

AZN main company
Sharemaestro market context Price below Trend Line 52 weeks -1.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks

This article first appeared on GuruFocus. AstraZeneca (NYSE:AZN), a global pharmaceutical company developing cancer, rare-disease and other medicines, plunged approximately 7.7% in Monday's U.S. regular-session trading as investors assessed reported merger discussions with Bristol Myers Squibb (NYSE:BMY), a U.S. biopharmaceutical company. A combination could …

AZN main company AZN1N main company AZN main company A1ZN34 main company AZN main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +14.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today

Bristol-Myers Squibb (BMY) shares opened higher on Monday following reports that the U.S. pharma giant held preliminary merger talks with UK rival AstraZeneca (AZN). If finalized, this reported transaction would create the world's largest drugmaker (by revenue) with a market cap approaching $400 billion. …

AZN main company AZN1N main company AZN main company A1ZN34 main company AZN main company AZN main company
Sharemaestro market context Price below Trend Line 52 weeks +14.4% AZN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PC Connection Sr. VP, CFO & Treasurer Sold Shares Worth Over $1.6M

Thomas C. Baker, Sr. VP, CFO & Treasurer of PC Connection (CNXN), sold common stock worth over $1.6 million on July 31, 2026. The sales involved 19,394 shares at $83.17 and 606 shares at $83.89. Following these transactions, Baker directly holds 36,092 shares.

CNXN main company
Sharemaestro market context Trend signal active 52 weeks +26.4% CNXN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context